Back to Search
AHMED BADAWI, MD, PHD
MD, PHD
Dermatology Physician
NPI: 1417319971IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
2020027936(MO)
Education
OTHER
Class of 2016
Research & Publications (20)
Solution interactions between the uranyl cation [UO2(2+)] and histidine, N-acetyl-histidine, tyrosine, and N-acetyl-tyrosine.
PMID 18947879·J Inorg Biochem·2009
8-other
Carbonic anhydrase inhibitors. Biphenylsulfonamides with inhibitory action towards the transmembrane, tumor-associated isozymes IX possess cytotoxic activity against human colon, lung and breast cancer cell lines.
PMID 18608752·J Enzyme Inhib Med Chem·2009
8-other
Chitosan based nanocarriers for indomethacin ocular delivery.
PMID 18787795·Arch Pharm Res·2008
7-preclinical
Patella sex determination by 3D statistical shape models and nonlinear classifiers.
PMID 17482786·Forensic Sci Int·2007
8-other
Surface and biocidal activity of some synthesized metallo azobenzene isothiouronium salts.
PMID 16973363·Bioorg Med Chem·2006
8-other
Application of artificial neural network in prediction of bladder outlet obstruction: a model based on objective, noninvasive parameters.
PMID 17169644·Urology·2006
8-other
Treatment of genital warts in males by pulsed dye laser.
PMID 16766488·J Cosmet Laser Ther·2006
8-other
Chemical destabilization of oil-in-water emulsion by novel polymerized diethanolamines.
PMID 15752798·J Colloid Interface Sci·2005
8-other
Improved measurement of dibenzo[a,l]pyrene-induced abasic sites by the aldehyde-reactive probe assay.
PMID 16298157·Mutat Res·2005
7-preclinical
Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer susceptible region of rat prostate.
PMID 16118231·Carcinogenesis·2005
7-preclinical
Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer susceptible region of rat prostate.
PMID 15117812·Carcinogenesis·2004
7-preclinical
Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis.
PMID 12455057·Int J Cancer·2003
4-observational
Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer.
PMID 12727798·Carcinogenesis·2003
8-other
Inhibition of cyclooxygenase-2 and activation of peroxisome proliferator-activated receptor-gamma synergistically induces apoptosis and inhibits growth of human breast cancer cells.
PMID 12736714·Int J Mol Med·2003
8-other
Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancer.
PMID 11872641·Carcinogenesis·2002
7-preclinical
Influence of cigarette smoking on prostaglandin synthesis and cyclooxygenase-2 gene expression in human urinary bladder cancer.
PMID 12197220·Cancer Invest·2002
8-other
DNA alkylation and repair in the large bowel: animal and human studies.
PMID 12421880·J Nutr·2002
6-review
Cyclooxygenase-2 inhibitor celecoxib inhibits promotion of mammary tumorigenesis in rats fed a high fat diet rich in n-6 polyunsaturated fatty acids.
PMID 12104042·Cancer Lett·2002
7-preclinical
Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma (Review).
PMID 12011987·Int J Oncol·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3401 MCINTOSH CIR STE 200
JOPLIN, MO 64804 - Phone
- (417) 347-8066
Quick Facts
- NPI
- 1417319971
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile